Reporting owner · CIK 0001509688

Schorno Dean L

Visual SEC Form 4 history across 1 companies, 15 transactions and 5 filings.

EVP, CFOEVP & Chief Financial OfficerRIGEL PHARMACEUTICALS INC
Open-market mix
Latest filingSep 03, 2026, 11:02 PM
Filings5Form 4 records
Buying$00 purchases
Selling$80.6K2 sales
Net value−$80.6KBuys minus sells
Companies13 securities
Most recentSep 02, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Jan 252Feb 25Feb 26Sep 26

Net value flow

Buys minus sells

Jan 25
$0
Feb 25
−$80.6K
Feb 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$40.3K
Median P/S size$40.3K
Direct15
Indirect0
Sep 02, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern1Derivative Transactionfiling-context1Direct Ownershipfiling-context6Large Holdings Increaseholdings2

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at RIGEL PHARMACEUTICALS INC on Feb 05, 2025 valued at $38,020.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at RIGEL PHARMACEUTICALS INC on Feb 05, 2025 valued at $38,020.

Review SEC filing

Associated companies

Visual map of known reporting history

RIGLRIGEL PHARMACEUTICALS INC15 transactions · latest Sep 03, 2026, 11:02 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
RIGLSchorno Dean L
EVPCFO
exercise1.28k$0M
Derivative Transaction Direct Ownership
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
exercise2.00k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
exercise620$0M
Derivative Transaction Direct Ownership
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
exercise694$0M
Derivative Transaction Direct Ownership
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
exercise1.28k$3.11MM
Direct Ownership
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
exercise2.00k$4.84MM
Direct Ownership
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
exercise620$1.15MM
Direct Ownership
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
exercise694$881kM
Direct Ownership
0.0%09/0309/02
RIGLSchorno Dean L
EVPCFO
withholding928-$4.40MF
Direct Ownership
0.0%09/0309/01
RIGLSchorno Dean L
EVPCFO
withholding3.54k-$12.2MF
Direct Ownership
−6.1%02/1202/10

Schorno Dean L Insider Activity FAQ

SEC Form 4 context

Who is Schorno Dean L?

Schorno Dean L is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001509688.

Which companies has Schorno Dean L reported transactions for?

RIGEL PHARMACEUTICALS INC

When was Schorno Dean L's latest insider buy?

No open-market insider purchase is available for this period.

When was Schorno Dean L's latest insider sale?

sale at RIGEL PHARMACEUTICALS INC on Feb 05, 2025 valued at $38,020.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.